Sort
64,565 grants matching “drug discovery”
Catalytic Methods for Building Block Assembly and for Stereoselective Glycosylation
$578,948John Montgomery · University Of Michigan At Ann Arbor · U01 · FY2019 · GM
Career Development and Outreach in Musculoskeletal, Autoimmune and Skin Disease
$578,932Mario Cerritelli · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIJ · FY2010 · AR
Novel NFAT1-MDM2 inhibitor for Breast Cancer Therapy
$578,917Ruiwen Zhang · University Of Houston · R01 · FY2018 · CA
Novel NFAT1-MDM2 inhibitor for Breast Cancer Therapy
$578,917Ruiwen Zhang · University Of Houston · R01 · FY2020 · CA
Novel NFAT1-MDM2 inhibitor for Breast Cancer Therapy
$578,917Ruiwen Zhang · University Of Houston · R01 · FY2021 · CA
Vaccina Virus DNA Topoisomerase
$578,913Stewart H Shuman · Sloan-Kettering Inst Can Research · R37 · FY2009 · GM
Antibiotic Drug Discovery
$578,911Toni B. Kline · University Of Washington · U54 · FY2013 · AI
Chemical Genetic Approaches to Study Chromatin Complexes
$578,864Brian Liau · Harvard University · R01 · FY2023 · CA
Basic Science
$578,838Fatah Kashanchi · George Washington University · P30 · FY2011 · AI
The mechanism of allosteric modulation of glutamate transporters
$578,817Andreia C K Mortensen · Drexel University · R01 · FY2021 · NS
Delineating Functional Immunity via Image-Guided PET
$578,749Nerissa Therese Viola · Wayne State University · R37 · FY2023 · CA
Development and characterization of peptidomimetic small molecule activators of peptidase neurolysin for stroke therapy.
$578,745Vardan T. Karamyan · Texas Tech University Health Scis Center · R01 · FY2019 · NS
Development and characterization of peptidomimetic small molecule activators of peptidase neurolysin for stroke therapy.
$578,745Vardan T. Karamyan · Texas Tech University Health Scis Center · R01 · FY2021 · NS
Development and characterization of peptidomimetic small molecule activators of peptidase neurolysin for stroke therapy.
$578,745Vardan T. Karamyan · Texas Tech University Health Scis Center · R01 · FY2020 · NS
OTHER FUNCTIONS TAS::75 0849::TAS; THIS MODIFICATION ADDS FUNDING FOR WA'S 2 AND
$578,722Emil Pop · Alchem Laboratories Corporation · N02 · FY2013 · CA
Coordinating Center for the Drug Induced Liver Injury Network (DILIN)
$578,630Huiman X Barnhart · Duke University · U24 · FY2018 · DK
Iron independent role for yersiniabactin in Yersinia pestis
$578,625Matthew Lawrenz · University Of Louisville · R01 · FY2021 · AI
HIV Reverse Transcriptase-Mediated Mutagenesis
$578,622Louis M Mansky · University Of Minnesota · R01 · FY2014 · GM
HIV Reverse Transcriptase-Mediated Mutagenesis
$578,622Louis M Mansky · University Of Minnesota · R01 · FY2015 · GM
HIV Reverse Transcriptase-Mediated Mutagenesis
$578,622Louis M Mansky · University Of Minnesota · R01 · FY2016 · GM
Development and Characterization of Peptidomimetic Small Molecule Activators of Peptidase Neurolysin for Stroke Therapy
$578,588Vardan T. Karamyan · Oakland University · R01 · FY2022 · NS
Unlocking the Potential of PI3K Inhibition in CLL
$578,547Jennifer R Brown · Dana-Farber Cancer Inst · R01 · FY2019 · CA
Human Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling
$578,512Joseph C Wu · Stanford University · R01 · FY2019 · HL
Towards Therapeutics for Neurodegenerative Diseases
$578,495Stanley B Prusiner · University Of California, San Francisco · R37 · FY2012 · AG
Enhancing Chemoradiation Efficacy through Unbiased Drug Discovery Approaches
$578,444Steven Hsesheng Lin · University Of Tx Md Anderson Can Ctr · U01 · FY2019 · CA